Page last updated: 2024-10-27

foscarnet and Emesis

foscarnet has been researched along with Emesis in 2 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research Excerpts

ExcerptRelevanceReference
"Foscarnet is a safe and effective agent for prevention of CMV disease in allogeneic transplant recipients unable to receive ganciclovir."2.68Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir. ( Andersson, B; Champlin, R; Gajewski, J; Giralt, S; Ippoliti, C; Khouri, I; Mehra, R; Morgan, A; Przepiorka, D; van Besien, K; Warkentin, D, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ippoliti, C1
Morgan, A1
Warkentin, D1
van Besien, K1
Mehra, R1
Khouri, I1
Giralt, S1
Gajewski, J1
Champlin, R1
Andersson, B1
Przepiorka, D1
Chakrabarti, S1
Collingham, KE1
Osman, H1
Fegan, CD1
Milligan, DW1

Trials

1 trial available for foscarnet and Emesis

ArticleYear
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
    Bone marrow transplantation, 1997, Volume: 20, Issue:6

    Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Fema

1997

Other Studies

1 other study available for foscarnet and Emesis

ArticleYear
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytos

2001